In the analysis of the whole study group, mean change in FEV 1 was 7.1% in the treatment arm versus 4.3% in the placebo group, and did not reach statistical significance ( p > 0.05).
← all excerpts
Targeting the PGD<sub>2</sub>/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.
1
0.0500
0.0500